Janus Kinase Inhibitors: A Promising Therapeutic Option for Allergic Contact Dermatitis
Cutis · 01.02.2023 · 111 (2)
DOI: 10.12788/cutis.0705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cutis, erschienen am 01.02.2023. Verfasst von Hadley Johnson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ms. Johnson is from the University of Minnesota Medical School, Minneapolis. Ms. Guenther is from the Keck School of Medicine, University of Southern…. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Skin Diseases, Psoriasis, Dermatitis, Allergic Contact. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ms. Johnson is from the University of Minnesota Medical School, Minneapolis. Ms. Guenther is from the Keck School of Medicine, University of Southern California, Los Angeles. Dr. Adler is from the Department of Dermatol…
Zitieren
APA
Johnson, H., Guenther, J., Adler, B. L., & Yu, J. (2023). Janus Kinase Inhibitors: A Promising Therapeutic Option for Allergic Contact Dermatitis. Cutis, 111(2). https://doi.org/10.12788/cutis.0705
Vancouver
Johnson H, Guenther J, Adler BL, Yu J. Janus Kinase Inhibitors: A Promising Therapeutic Option for Allergic Contact Dermatitis. Cutis. 2023;111(2). doi:10.12788/cutis.0705
BibTeX
@article{Johnson2023,
author = {Johnson, Hadley and Guenther, Jana and Adler, Brandon L and Yu, JiaDe},
title = {Janus Kinase Inhibitors: A Promising Therapeutic Option for Allergic Contact Dermatitis},
journal = {Cutis},
year = {2023},
volume = {111},
number = {2},
doi = {10.12788/cutis.0705}
}
EUVIMED